Janney Montgomery Scott LLC
Position in VNDA — Vanda Pharmaceuticals Inc.
CIK 1329948
PHILADELPHIA, PA
Position in VNDA
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$949,536
-$259,741 QoQ
Shares Held
155,153
-11.3% QoQ
Ownership
0.257%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#43
of 172 holders
Holding Since
Mar 2020
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in VNDA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Janney Montgomery Scott LLC holds $121,989,266 across 55 Biotechnology names. VNDA ranks #22 (0.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
85,735 | $42,587,146 | |
| 2 | SPRY |
ARS Pharmaceuticals, Inc.
|
2,064,498 | $16,536,628 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
12,176 | $7,592,223 | |
| 4 | INCY |
Incyte Corp
|
52,727 | $5,977,132 | |
| 5 | EXEL |
Exelixis, Inc.
|
89,664 | $4,878,618 | |
| 6 | ZVRA |
Zevra Therapeutics, Inc.
|
272,194 | $3,903,261 | |
| 7 | AXSM |
Axsome Therapeutics, Inc.
|
13,087 | $3,203,304 | |
| 8 | ROIV |
Roivant Sciences Ltd.
|
79,550 | $2,815,274 |
All Filings in VNDA
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $949,536 | 155,153 | Shares | Sole | 2026-08-05 | |
| 2026-03-31 | $1,209,277 | 175,004 | Shares | Sole | 2026-04-22 | |
| 2025-12-31 | $1,548,271 | 175,541 | Shares | Sole | 2026-02-11 | |
| 2020-12-31 ALXN | — | 38,451 | Shares | Sole | 2021-01-25 | |
| 2020-09-30 ALXN | — | 45,106 | Shares | Sole | 2020-11-06 | |
| 2020-06-30 ALXN | — | 43,829 | Shares | Sole | 2020-07-23 | |
| 2020-03-31 ALXN | — | 44,221 | Shares | Sole | 2020-04-30 | |
| No filing history on record for this holder in this stock. | ||||||